Update on novel familial forms of Parkinson's disease and multiple system atrophy
- PMID: 24262183
- PMCID: PMC4215194
- DOI: 10.1016/S1353-8020(13)70010-5
Update on novel familial forms of Parkinson's disease and multiple system atrophy
Abstract
Parkinson's disease (PD) and multiple system atrophy (MSA) are progressive neurodegenerative disorders classified as synucleinopathies, which are defined by the presence of α-synuclein protein pathology. Genetic studies have identified a total of 18 PARK loci that are associated with PD. The SNCA gene encodes the α-synuclein protein. The first pathogenic α-synuclein p.A53T substitution was discovered in 1997; this was followed by the identification of p.A30P and p.E46K pathogenic substitutions in 1998 and 2004, respectively. In the last year, two possible α-synuclein pathogenic substitutions, p.A18T and p.A29S, and two probable pathogenic substitutions, p.H50Q and p.G51D have been nominated. Next-generation sequencing approaches in familial PD have identified mutations in the VPS35 gene. A VPS35 p.D620N substitution remains the only confirmed pathogenic substitution. A second synucleinopathy, MSA, originally was considered a sporadic condition with little or no familial aggregation. However, recessive COQ2 mutations recently were nominated to be the genetic cause in a subset of familial and sporadic MSA cases. Further studies on the clinicogenetics and pathology of parkinsonian disorders will facilitate clarification of the molecular characteristics and pathomechanisms underlying these disorders.
Keywords: Familial; Genetics; MSA; PD; SNCA; VPS35.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Conflict of interest statement
All authors have no conflict of interest in relation to this manuscript.
Figures
References
-
- Puschmann A, Bhidayasiri R, Weiner WJ. Synucleinopathies from bench to bedside. Parkinsonism & related disorders. 2012;18 (Suppl 1):S24–7. - PubMed
-
- McDonnell SK, Schaid DJ, Elbaz A, Strain KJ, Bower JH, Ahlskog JE, et al. Complex segregation analysis of Parkinson’s disease: The Mayo Clinic Family Study. Ann Neurol. 2006;59:788–95. - PubMed
-
- Sundal C, Fujioka S, Uitti RJ, Wszolek ZK. Autosomal dominant Parkinson’s disease. Parkinsonism & related disorders. 2012;18 (Suppl 1):S7–10. - PubMed
-
- Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med. 2013;369:233–44. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
